Cross-cohort Analysis Identified an Immune Checkpoint-Based Signature to Predict the Clinical Outcomes of Neuroblastoma.
JOURNAL FOR IMMUNOTHERAPY OF CANCER（2023）
Key words
neuroblastoma,tumor microenvironment,tumor biomarkers
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined